205 related articles for article (PubMed ID: 30871027)
1. HIV Replication in Humanized IL-3/GM-CSF-Transgenic NOG Mice.
Perdomo-Celis F; Medina-Moreno S; Davis H; Bryant J; Zapata JC
Pathogens; 2019 Mar; 8(1):. PubMed ID: 30871027
[TBL] [Abstract][Full Text] [Related]
2. The Tumor Milieu Promotes Functional Human Tumor-Resident Plasmacytoid Dendritic Cells in Humanized Mouse Models.
Maser IP; Hoves S; Bayer C; Heidkamp G; Nimmerjahn F; Eckmann J; Ries CH
Front Immunol; 2020; 11():2082. PubMed ID: 33013879
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a human allergy model using human IL-3/GM-CSF-transgenic NOG mice.
Ito R; Takahashi T; Katano I; Kawai K; Kamisako T; Ogura T; Ida-Tanaka M; Suemizu H; Nunomura S; Ra C; Mori A; Aiso S; Ito M
J Immunol; 2013 Sep; 191(6):2890-9. PubMed ID: 23956433
[TBL] [Abstract][Full Text] [Related]
4. Humanization with CD34-positive hematopoietic stem cells in NOG-EXL mice results in improved long-term survival and less severe myeloid cell hyperactivation phenotype relative to NSG-SGM3 mice.
Willis E; Verrelle J; Banerjee E; Assenmacher CA; Tarrant JC; Skuli N; Jacobson ML; O'Rouke DM; Binder ZA; Radaelli E
Vet Pathol; 2024 Jan; ():3009858231222216. PubMed ID: 38197423
[TBL] [Abstract][Full Text] [Related]
5. Improved B cell development in humanized NOD
Jangalwe S; Shultz LD; Mathew A; Brehm MA
Immun Inflamm Dis; 2016 Dec; 4(4):427-440. PubMed ID: 27980777
[TBL] [Abstract][Full Text] [Related]
6. High activation and skewed T cell differentiation are associated with low IL-17A levels in a hu-PBL-NSG-SGM3 mouse model of HIV infection.
Perdomo-Celis F; Medina-Moreno S; Davis H; Bryant J; Taborda NA; Rugeles MT; Kottilil S; Zapata JC
Clin Exp Immunol; 2020 May; 200(2):185-198. PubMed ID: 31951011
[TBL] [Abstract][Full Text] [Related]
7. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse.
Ashizawa T; Iizuka A; Nonomura C; Kondou R; Maeda C; Miyata H; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Katano I; Ito M; Akiyama Y
Clin Cancer Res; 2017 Jan; 23(1):149-158. PubMed ID: 27458246
[TBL] [Abstract][Full Text] [Related]
8. Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse.
Katano I; Takahashi T; Ito R; Kamisako T; Mizusawa T; Ka Y; Ogura T; Suemizu H; Kawakami Y; Ito M
J Immunol; 2015 Apr; 194(7):3513-25. PubMed ID: 25712215
[TBL] [Abstract][Full Text] [Related]
9. Generation of Human Immunosuppressive Myeloid Cell Populations in Human Interleukin-6 Transgenic NOG Mice.
Hanazawa A; Ito R; Katano I; Kawai K; Goto M; Suemizu H; Kawakami Y; Ito M; Takahashi T
Front Immunol; 2018; 9():152. PubMed ID: 29456539
[TBL] [Abstract][Full Text] [Related]
10. Improved Detection of
Katano I; Ito R; Kawai K; Takahashi T
Front Immunol; 2020; 11():532684. PubMed ID: 33117338
[TBL] [Abstract][Full Text] [Related]
11. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs.
Vremec D; Lieschke GJ; Dunn AR; Robb L; Metcalf D; Shortman K
Eur J Immunol; 1997 Jan; 27(1):40-4. PubMed ID: 9021996
[TBL] [Abstract][Full Text] [Related]
12. Long-term maintenance of peripheral blood derived human NK cells in a novel human IL-15- transgenic NOG mouse.
Katano I; Nishime C; Ito R; Kamisako T; Mizusawa T; Ka Y; Ogura T; Suemizu H; Kawakami Y; Ito M; Takahashi T
Sci Rep; 2017 Dec; 7(1):17230. PubMed ID: 29222435
[TBL] [Abstract][Full Text] [Related]
13. NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models.
Ito M; Kobayashi K; Nakahata T
Curr Top Microbiol Immunol; 2008; 324():53-76. PubMed ID: 18481452
[TBL] [Abstract][Full Text] [Related]
14. Introduction of Human Flt3-L and GM-CSF into Humanized Mice Enhances the Reconstitution and Maturation of Myeloid Dendritic Cells and the Development of Foxp3
Iwabuchi R; Ikeno S; Kobayashi-Ishihara M; Takeyama H; Ato M; Tsunetsugu-Yokota Y; Terahara K
Front Immunol; 2018; 9():1042. PubMed ID: 29892279
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells.
Carbonneil C; Aouba A; Burgard M; Cardinaud S; Rouzioux C; Langlade-Demoyen P; Weiss L
AIDS; 2003 Aug; 17(12):1731-40. PubMed ID: 12891059
[TBL] [Abstract][Full Text] [Related]
16. Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain.
Coughlan AM; Harmon C; Whelan S; O'Brien EC; O'Reilly VP; Crotty P; Kelly P; Ryan M; Hickey FB; O'Farrelly C; Little MA
Stem Cells Dev; 2016 Apr; 25(7):530-41. PubMed ID: 26879149
[TBL] [Abstract][Full Text] [Related]
17. A Comparison of Lymphoid and Myeloid Cells Derived from Human Hematopoietic Stem Cells Xenografted into NOD-Derived Mouse Strains.
Gutierrez-Barbosa H; Medina-Moreno S; Perdomo-Celis F; Davis H; Coronel-Ruiz C; Zapata JC; Chua JV
Microorganisms; 2023 Jun; 11(6):. PubMed ID: 37375051
[TBL] [Abstract][Full Text] [Related]
18. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
[TBL] [Abstract][Full Text] [Related]
19. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
[TBL] [Abstract][Full Text] [Related]
20. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
Kim KC; Choi BS; Kim KC; Park KH; Lee HJ; Cho YK; Kim SI; Kim SS; Oh YK; Kim YB
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):194-202. PubMed ID: 26564392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
